<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD04530000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>Q13951</UniProt_ID>
  <Seq_Length>182</Seq_Length>
  <Molecule_Weight>21508</Molecule_Weight>
  <KEGG_ID>hsa:865</KEGG_ID>
  <EBI_ID>EBI-718750</EBI_ID>
  <Function_Summary>CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL3 and GM-CSF promoters. CBFB enhances DNA binding by RUNX1.</Function_Summary>
  <Pfam_ID>PF02312:CBF_beta</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>21</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>CBF-beta</Alias>
      <Alias>PEA2-beta</Alias>
      <Alias>PEBP2-beta</Alias>
      <Alias>SL3/AKV core-binding factor beta subunit</Alias>
      <Alias>Polyomavirus enhancer-binding protein 2 beta subunit</Alias>
      <Alias>SL3-3 enhancer factor 1 subunit beta</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).</Detail>
      <Keyword>Protein binding</Keyword>
      <Ontology_ID>GO:0005515</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription. The transcription factor may or may not also interact selectively with a protein or macromolecular complex.</Detail>
      <Keyword>Sequence-specific DNA binding transcription factor activity</Keyword>
      <Ontology_ID>GO:0003700</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a activating transcription factor and also with the basal transcription machinery in order to increase the frequency, rate or extent of transcription. Cofactors generally do not bind DNA, but rather mediate protein-protein interactions between activating transcription factors and the basal transcription machinery.</Detail>
      <Keyword>Transcription coactivator activity</Keyword>
      <Ontology_ID>GO:0003713</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>100</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The synthesis of RNA from a DNA template by RNA polymerase II (Pol II), originating at a Pol II-specific promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).</Detail>
      <Keyword>Transcription from RNA polymerase II promoter</Keyword>
      <Ontology_ID>GO:0006366</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>11</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPSREYVDLEREAGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQQEDALAQQAFEEARRRTREFEDRDRSHREEMEVRVSQLLAVTGKKTTRP</Protein_Seq>
    <DNA_Seq>GCGGTGAGCGCTGGGGCTGCGCGGGCGGCAGGCAACGGCTGAGGCGGCGGCGGCGGCGGCGGCGGCGTGGGTTGGGCTCGAGCGGGCGGCGGCGCCTCAGACTCCCCGGAACGGGAGCCCACGCGGGCGGGCGCCTGAAACAAAGGGAAGCGGGCGTCCGGGCGCCGCGGGTGGGCGGTCAGTCGGTCAGCGCGGAGCCAGCCAGCGGGTGCCCGCGCAAGCCCCGAGCGCGGCCGGCCGGCGCGGCCTCAGGGCGGGAAGATGCCGCGCGTCGTGCCCGACCAGAGAAGCAAGTTCGAGAACGAGGAGTTTTTTAGGAAGCTGAGCCGCGAGTGTGAGATTAAGTACACGGGCTTCAGGGACCGGCCCCACGAGGAACGCCAGGCACGCTTCCAGAACGCCTGCCGCGACGGCCGCTCGGAAATCGCTTTTGTGGCCACAGGAACCAATCTGTCTCTCCAGTTTTTTCCGGCCAGCTGGCAGGGAGAACAGCGACAAACACCTAGCCGAGAGTATGTCGACTTAGAAAGAGAAGCAGGCAAGGTATATTTGAAGGCTCCCATGATTCTGAATGGAGTCTGTGTTATCTGGAAAGGCTGGATTGATCTCCAAAGACTGGATGGTATGGGCTGTCTGGAGTTTGATGAGGAGCGAGCCCAGCAGGAGGATGCATTAGCACAACAGGCCTTTGAAGAGGCTCGGAGAAGGACACGCGAATTTGAAGATAGAGACAGGTCTCATCGGGAGGAAATGGAGGTGAGAGTTTCACAGCTGCTGGCAGTAACTGGCAAGAAGACAACAAGACCCTAGTCCTGGTTCCAATTTAGGTGGTGGTGATGACCTCAAACTTCGTTAATTAATAGCACAGCAGATGTGTGCTGCCCATCTTTACATACACATTGCTTCTAGTTGGCAGAAATAATTGATTAAAAGACCAGAAACTGTGATAACTGGAGGTACTACGGTCTATTTCTCAACCTTAGGCAGTAATAGACATCACAAACTGCCATGGTTTTGCACTATGATTATAATACCTGCATTTCTAATTTTTTAAGCATGTAGCCAGTAATAATTTGAAGTTTTTTTTCTATGCAAGCTTACCTTGTTGGCATTATTTTAGGGAGTTGAAACTATCAACTGTAAAGCTCCTTTTCTTCCACTTTAATTTAAAAGTTCATGTCATTTAAAAACAAGTCAAGAAATTAAAATTGTATCAGAGGGTTTTCTCTAATCATTTTTTCTATTTTTTTTTTTGTACTTCTAGATGTTTTGGTTATACAGCTTCATTTTAGATGAGCATTCTTATTTTTTGTTTTGTTTGCCCCATTTCCTTTTGTGTTTTTATAGTCTATAGCATTTTAAAACTGCTGATGTTGTTTGCATTATTTACAGGCTAAAAACTTAGTAGCATAGAGCTGTCTGCCACAGCCTTCTGACAAAGTTTACAGTTATTAAAGTTGCAGTATCCTTTTAAATGCTAGTAATCAGCACTCTTTCTTTTTTTTTTTTTTAATAGAGACAGGGTCTCGCAGTGTTGCCCAGGCTGGTCTCGAACTCCTGGCATCAAGCGATCCTCCTGCCTTAGCCTCCCAGAGTACTGGGATTACAGGCTCTTTCTTTTTAAACATAAAAGTTTTAAATTGGTATTAACTCTGTACTCTGCCCTAGATTGTTTTAGCTTCTGTTCTGTAATCATGAGTTTGGTTGGAGATATTCTCCATAGATGATCTTCTACTGAAATGCCTAAAGAAGTCACAGGCTGGCTTCTGTTTTATTCAGGGATTTTTTTAAAAAGTCAATCAGAAAAGGGATACTGGAGCTTCTTCATGTATGTAACAGCATATTAAACTGGAGACAGTGATGAATCAGCTACAAAGGTAATATTGTATTAAAATCATGTTTAAGATAGCTGCTTTTATGTGTATTTTATATTGCATGCTTTTGTAAAAACATGCTGGGTGATGAAAGATTAGTTTTAGAGAGAAAATGTTCATCTGTGCAGAGGATGCATTTTCTTCCATTAATTCTGGAAAAAACGTTCACAGTTATATATATGGTATTTTGCAAAAGGACTATTAATAGAACCTTTTGAGATGAATTAATGTAAGAATATTTTTTAAATAGGCTTACTGTCAAATTGCAACTTTTTTTTTAGATACAGAGTGGAAAACAGTGCTAAGTCATTTGGCACCTCCTTACAAATATTTTTCATGGTCACATTTATTAAATGTTACTACATTTCTGAATTTTTGAAAAATGTATTTTATCATTAAATGGCATTATTTTAAAGGGTGAAAAACTGACACAGTCAATTCAGAAAATGGACTGAAGTCTGAATAAGGTCATTGCATTTAAAAAGCATATAACTGTACTTGACTGATGAGGGAGGTGTTACTTTCATTGTATATAGGTCTTATTTCATAAACAGATATCCTGTATCAAATAAAAGTATTTGTTATATATTTGAAGTTATGCATGGAAAGGAGTGTGTTTAAATTGTTACAAACAATAATGCGTCATTAAAGGCCATGCTGATCTTGCATAACTATAAGTACTATGAATGAATTTGGTTGGTTTTGGTGTTGTACAGCTCACATGTTTACACACTCAGTGCCCTAATTTCCCCTGAGGGAATCGCTTTTTAAGTGATCCTTACAGTGGTGTTTTATGTTACTTTATTACAGAGCTCCTTGGTTTTTTACTTCTGCACTTAAATTTTTTTAAATAACATGATGATGGTACATTTTCCTCTATTGTCTAGCTAAGGGCTTTCGGTCCACCAGTAAATAAGATCAAATGCTCTTAAATGTTCCTGTTACCATCCTAATGTAAATACTGGATTTTTCTGTCATTTAGCACCATGCTGCTTCTGTCTGTCTTAATGCTGGCATTAAGATCATGAGCCCTTTTTCTCCAGTAGTACAGGCTTTGAAAACTACTTCTATTAAGTTATTGATGCAATTTGATATTTTTTCATAATCTATATTTAAACAAAATTACATCATTGCATCATCTTTTCTAAATTCATCTCCATTAAAACTTGCCTTAAGCTACCAGATTGCTTTTGCCACCATTGGCCATACTGTGTGTTTGTTTGTTTAATTTACTTTCACAATAAACTTCTGTGTAGTAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
      <Ontology_ID>GO:0005634</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>CBFB</Gene_Name>
    <Gene_ID>865</Gene_ID>
    <Genbank_ACCN>NM_001755</Genbank_ACCN>
    <Protein_ACCN>NP_001746</Protein_ACCN>
    <HGNC_ID>1539</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/865</Gene_URL>
    <UCSC_ID>uc002erb.3</UCSC_ID>
    <EMBL_ID>ENSG00000067955</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P11137</Uniprot_ID>
      <Gene_Name>MAP2</Gene_Name>
      <EBI_ID>EBI-2682460</EBI_ID>
      <PPI_EBI_URL>EBI-718750,EBI-2682460</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9NVM9</Uniprot_ID>
      <Gene_Name>Asun</Gene_Name>
      <EBI_ID>EBI-741429</EBI_ID>
      <PPI_EBI_URL>EBI-718750,EBI-741429</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Myeloid Leukemia</Disease_Name>
      <Disease_Detail>Myeloid Leukemia</Disease_Detail>
      <Disease_DB>MYL006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myeloid_leukemia?search=CBFB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acute Myeloid Leukemia with Abnormal Bone Marrow Eosinophils Inv(16)(p13q22) or T(16;16)(p13;q22)'</Disease_Name>
      <Disease_Detail>Acute Myeloid Leukemia with Abnormal Bone Marrow Eosinophils Inv(16)(p13q22) or T(16;16)(p13;q22)'</Disease_Detail>
      <Disease_DB>ACT207</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acute_myeloid_leukemia_with_abnormal_bone_marrow_eosinophils_inv16p13q22_or_t1616p13q22_2?search=CBFB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Imperforate Anus</Disease_Name>
      <Disease_Detail>Imperforate Anus</Disease_Detail>
      <Disease_DB>IMP002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/imperforate_anus?search=CBFB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Core Binding Factor Acute Myeloid Leukemia</Disease_Name>
      <Disease_Detail>Core Binding Factor Acute Myeloid Leukemia</Disease_Detail>
      <Disease_DB>CRB138</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/core_binding_factor_acute_myeloid_leukemia?search=CBFB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Myeloid Leukemia, Acute, M4/m4eo Subtype, Somatic</Disease_Name>
      <Disease_Detail>Acute Myeloid Leukemia</Disease_Detail>
      <Disease_DB>MYL050</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myeloid_leukemia_acute_m4_m4eo_subtype_somatic?search=CBFB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acute Myeloid Leukemia</Disease_Name>
      <Disease_Detail>Acute Myeloid Leukemia</Disease_Detail>
      <Disease_DB>ACT019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acute_myeloid_leukemia?search=CBFB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acute Myelomonocytic Leukemia</Disease_Name>
      <Disease_Detail>Acute Myelomonocytic Leukemia</Disease_Detail>
      <Disease_DB>ACT117</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acute_myelomonocytic_leukemia?search=CBFB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lymphoplasmacytic Lymphoma</Disease_Name>
      <Disease_Detail>Lymphoplasmacytic Lymphoma</Disease_Detail>
      <Disease_DB>LYM012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lymphoplasmacytic_lymphoma?search=CBFB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cleidocranial Dysplasia</Disease_Name>
      <Disease_Detail>Cleidocranial Dysplasia</Disease_Detail>
      <Disease_DB>CLD001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cleidocranial_dysplasia?search=CBFB#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>AML1/CBF COMPLEX</PDB_Title>
      <PDB_ID>1E50</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1E50</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Basis for the Heterodimeric Interaction between the Acute Leukaemia-Associated Transcription Factors Aml1 and Cbfbeta</PubMed_Title>
      <Author>Warren, A.J., et al.</Author>
      <Journal>Embo J.(2000)19:3004-3015</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10856244?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>AML1/CBF-BETA/DNA COMPLEX</PDB_Title>
      <PDB_ID>1H9D</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1H9D</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Leukemia-Associated Aml1 (Runx1)-Cbfbeta Complex Functions as a DNA-Induced Molecular Clamp</PubMed_Title>
      <Author>Bravo, J., et al.</Author>
      <Journal>Nat.Struct.Biol.(2001)8:371</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11276260?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>MOLECULAR INSIGHTS INTO PEBP2/CBF-SMMHC ASSOCIATED ACUTE LEUKEMIA REVEALED FROM THE THREE-DIMENSIONAL STRUCTURE OF PEBP2/CBF BETA</PDB_Title>
      <PDB_ID>1CL3</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1CL3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Molecular insights into PEBP2/CBF beta-SMMHC associated acute leukemia revealed from the structure of PEBP2/CBF beta</PubMed_Title>
      <Author>Goger, M., et al.</Author>
      <Journal>Nat.Struct.Biol.(1999)6:620-623</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10404215?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Fold>
    <SCOP_Class>All beta proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.c.ja.b.b.b.html</SCOP_URL>
    <CATH_Class>Class 2: Mainly Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1h9d</CATH_URL>
  </Fold>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD01120128</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04530003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04530004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04530005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04530006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04530007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04530008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04530009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04530010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04530011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04530012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04530013</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04530014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04530015</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04530016</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04530017</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04530018</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04530019</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04530020</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04530021</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04530022</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>